The Role of Transporters in the Pharmacokinetics of Orally Administered Drugs

被引:318
作者
Shugarts, Sarah [1 ]
Benet, Leslie Z. [1 ]
机构
[1] Univ Calif San Francisco, Dept Biopharmaceut Sci, San Francisco, CA 94143 USA
关键词
BDDCS; drug transporters; hepatic; intestinal; transporter/enzyme interplay; PREGNANE-X-RECEPTOR; CONSTITUTIVE ANDROSTANE RECEPTOR; INTESTINAL P-GLYCOPROTEIN; CANCER RESISTANCE PROTEIN; ORGANIC CATION TRANSPORTERS; ATP-BINDING CASSETTE; CONCENTRATIVE NUCLEOSIDE TRANSPORTER; MEMBRANE MONOAMINE TRANSPORTER; BLOOD-BRAIN-BARRIER; OATP-C SLC21A6;
D O I
10.1007/s11095-009-9924-0
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Drug transporters are recognized as key players in the processes of drug absorption, distribution, metabolism, and elimination. The localization of uptake and efflux transporters in organs responsible for drug biotransformation and excretion gives transporter proteins a unique gatekeeper function in controlling drug access to metabolizing enzymes and excretory pathways. This review seeks to discuss the influence intestinal and hepatic drug transporters have on pharmacokinetic parameters, including bioavailability, exposure, clearance, volume of distribution, and half-life, for orally dosed drugs. This review also describes in detail the Biopharmaceutics Drug Disposition Classification System (BDDCS) and explains how many of the effects drug transporters exert on oral drug pharmacokinetic parameters can be predicted by this classification scheme.
引用
收藏
页码:2039 / 2054
页数:16
相关论文
共 170 条
[1]  
Allen JD, 2002, MOL CANCER THER, V1, P417
[2]   A THEORETICAL BASIS FOR A BIOPHARMACEUTIC DRUG CLASSIFICATION - THE CORRELATION OF IN-VITRO DRUG PRODUCT DISSOLUTION AND IN-VIVO BIOAVAILABILITY [J].
AMIDON, GL ;
LENNERNAS, H ;
SHAH, VP ;
CRISON, JR .
PHARMACEUTICAL RESEARCH, 1995, 12 (03) :413-420
[3]   Human bile salt export pump promoter is transactivated by the farnesoid X receptor/bile acid receptor [J].
Ananthanarayanan, M ;
Balasubramanian, N ;
Makishima, M ;
Mangelsdorf, DJ ;
Suchy, FJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (31) :28857-28865
[4]   The MDCK cell line is made up of populations of cells with diverse resistive and transport properties [J].
Arthur, JM .
TISSUE & CELL, 2000, 32 (05) :446-450
[5]   Interactions between hepatic Mrp4 and Sult2a as revealed by the constitutive androstane receptor and Mrp4 knockout mice [J].
Assem, M ;
Schuetz, EG ;
Leggas, M ;
Sun, DX ;
Yasuda, K ;
Reid, G ;
Zelcer, N ;
Adachi, M ;
Strom, S ;
Evans, RM ;
Moore, DD ;
Borst, P ;
Schuetz, JD .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (21) :22250-22257
[6]   Expression, localisation and activity of ATP binding cassette (ABC) family of drug transporters in human amnion membranes [J].
Aye, I. L. M. H. ;
Paxton, J. W. ;
Evseenko, D. A. ;
Keelan, J. A. .
PLACENTA, 2007, 28 (8-9) :868-877
[7]   Naringin is a major and selective clinical inhibitor of organic anion-transporting polypeptide 1A2 (OATP1A2) in grapefruit juice [J].
Bailey, D. G. ;
Dresser, G. K. ;
Leake, B. F. ;
Kim, R. B. .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2007, 81 (04) :495-502
[8]   The use of BDDCS in classifying the permeability of marketed drugs [J].
Benet, Leslie Z. ;
Amidon, Gordon L. ;
Barends, Dirk M. ;
Lennernas, Hans ;
Polli, James E. ;
Shah, Vinod P. ;
Stavchansky, Salomon A. ;
Yu, Lawrence X. .
PHARMACEUTICAL RESEARCH, 2008, 25 (03) :483-488
[9]   Intestinal MDR transport proteins and P-450 enzymes as barriers to oral drug delivery [J].
Benet, LZ ;
Izumi, T ;
Zhang, YC ;
Silverman, JA ;
Wacher, VJ .
JOURNAL OF CONTROLLED RELEASE, 1999, 62 (1-2) :25-31
[10]   Activation of CFTR by ASBT-mediated bile salt absorption [J].
Bijvelds, MJC ;
Jorna, H ;
Verkade, HJ ;
Bot, AGM ;
Hofmann, F ;
Agellon, LB ;
Sinaasappel, M ;
de Jonge, HR .
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2005, 289 (05) :G870-G879